Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

CHO Pharma, Inc. (6586) Financial Statements

CHO Pharma, Inc. Financial Overview

CHO Pharma, Inc.'s market cap is currently NT$15.92B. The company's EPS TTM is NT$-1.25; its P/E ratio is -60.72; CHO Pharma, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 1.43MNT$ 3.58MNT$ 0.00NT$ 60.00KNT$ 3.57M
Gross ProfitNT$ -25.54MNT$ 1.71MNT$ -28.28MNT$ 59.00KNT$ 3.36M
Operating IncomeNT$ -325.84MNT$ -249.29MNT$ -269.00MNT$ -350.90MNT$ -210.49M
EBITDANT$ -299.15MNT$ -185.65MNT$ -277.73MNT$ -298.24MNT$ -166.27M
Net IncomeNT$ -290.01MNT$ -212.23MNT$ -306.09MNT$ -338.39MNT$ -205.93M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 2.06BNT$ 2.37BNT$ 2.60BNT$ 1.04BNT$ 1.32B
Total AssetsNT$ 2.57BNT$ 2.88BNT$ 3.09BNT$ 1.60BNT$ 1.89B
Total DebtNT$ 14.59MNT$ 28.90MNT$ 0.00NT$ 11.70MNT$ 25.56M
Net DebtNT$ -37.50MNT$ 7.09MNT$ -203.79MNT$ -493.96MNT$ -752.42M
Total LiabilitiesNT$ 109.06MNT$ 132.57MNT$ 110.83MNT$ 173.69MNT$ 149.71M
Stockholders' EquityNT$ 2.46BNT$ 2.75BNT$ 2.98BNT$ 1.43BNT$ 1.74B
Cash Flow
Free Cash FlowNT$ -288.87MNT$ -222.87MNT$ -293.13MNT$ -258.90MNT$ -196.11M
Operating Cash FlowNT$ -279.57MNT$ -217.38MNT$ -291.13MNT$ -249.50MNT$ -193.47M
Investing Cash FlowNT$ 324.19MNT$ 49.40MNT$ -1.86BNT$ -9.01MNT$ -3.03M
Financing Cash FlowNT$ -14.31MNT$ -14.04MNT$ 1.85BNT$ -13.90MNT$ -11.31M

Currency in TWD

CHO Pharma, Inc. Earnings and Revenue History

-400M-200M0200M-600000 %-400000 %-200000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

CHO Pharma, Inc. Liabilities to Assets

01.2B2.4B3.6B0 %4 %8 %12 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

CHO Pharma, Inc. Cash Flow

-3B-2B-1B01B2B3B201720182019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

CHO Pharma, Inc. Forecast EPS vs Actual EPS

Earnings >